Lataa...
Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
The treatment of various central nervous system (CNS) diseases has been challenging, despite the rapid development of several novel treatment approaches. The blood–brain barrier (BBB) is one of the major issues in the treatment of CNS diseases, having major role in the protection of the brain but si...
Tallennettuna:
| Julkaisussa: | Pharmaceutics |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7767046/ https://ncbi.nlm.nih.gov/pubmed/33352959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12121230 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|